| Year |
Citation |
Score |
| 2010 |
Erster O, Seger R, Liscovitch M. Ligand interaction scan (LIScan) in the study of ERK8. Biochemical and Biophysical Research Communications. 399: 37-41. PMID 20638370 DOI: 10.1016/J.Bbrc.2010.07.029 |
0.356 |
|
| 2010 |
Shatz M, Lustig G, Reich R, Liscovitch M. Caveolin-1 mutants P132L and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells. Experimental Cell Research. 316: 1748-62. PMID 20153318 DOI: 10.1016/J.Yexcr.2010.02.006 |
0.667 |
|
| 2008 |
Ravid D, Chuderland D, Landsman L, Lavie Y, Reich R, Liscovitch M. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Experimental Cell Research. 314: 2762-73. PMID 18598695 DOI: 10.1016/J.Yexcr.2008.06.004 |
0.483 |
|
| 2008 |
Tencer L, Burgermeister E, Ebert MP, Liscovitch M. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance. Anticancer Research. 28: 895-906. PMID 18507034 |
0.378 |
|
| 2008 |
Burgermeister E, Liscovitch M, Röcken C, Schmid RM, Ebert MP. Caveats of caveolin-1 in cancer progression. Cancer Letters. 268: 187-201. PMID 18482795 DOI: 10.1016/J.Canlet.2008.03.055 |
0.429 |
|
| 2008 |
Shatz M, Liscovitch M. Caveolin-1: a tumor-promoting role in human cancer. International Journal of Radiation Biology. 84: 177-89. PMID 18300018 DOI: 10.1080/09553000701745293 |
0.728 |
|
| 2007 |
Burgermeister E, Xing X, Röcken C, Juhasz M, Chen J, Hiber M, Mair K, Shatz M, Liscovitch M, Schmid RM, Ebert MP. Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Research. 67: 8519-26. PMID 17875691 DOI: 10.1158/0008-5472.Can-07-1125 |
0.727 |
|
| 2007 |
Burgermeister E, Chuderland D, Hanoch T, Meyer M, Liscovitch M, Seger R. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma. Molecular and Cellular Biology. 27: 803-17. PMID 17101779 DOI: 10.1128/Mcb.00601-06 |
0.371 |
|
| 2007 |
Liscovitch M, Ravid D. A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Letters. 245: 350-2. PMID 16504380 DOI: 10.1016/J.Canlet.2006.01.013 |
0.422 |
|
| 2006 |
Glait C, Tencer L, Ravid D, Sarfstein R, Liscovitch M, Werner H. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways. Experimental Cell Research. 312: 3899-908. PMID 17014845 DOI: 10.1016/J.Yexcr.2006.08.016 |
0.423 |
|
| 2006 |
Glait C, Ravid D, Lee SW, Liscovitch M, Werner H. Caveolin-1 controls BRCA1 gene expression and cellular localization in human breast cancer cells. Febs Letters. 580: 5268-74. PMID 16979166 DOI: 10.1016/J.Febslet.2006.08.071 |
0.407 |
|
| 2006 |
Ravid D, Maor S, Werner H, Liscovitch M. Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells. Advances in Enzyme Regulation. 46: 163-75. PMID 16857240 DOI: 10.1016/J.Advenzreg.2006.01.022 |
0.32 |
|
| 2005 |
Ravid D, Maor S, Werner H, Liscovitch M. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Oncogene. 24: 1338-47. PMID 15592498 DOI: 10.1038/Sj.Onc.1208337 |
0.476 |
|
| 2004 |
Shatz M, Liscovitch M. Caveolin-1 and cancer multidrug resistance: coordinate regulation of pro-survival proteins? Leukemia Research. 28: 907-8. PMID 15234566 DOI: 10.1016/J.Leukres.2004.03.013 |
0.704 |
|
| 2003 |
Preise D, Mazor O, Koudinova N, Liscovitch M, Scherz A, Salomon Y. Bypass of tumor drug resistance by antivascular therapy. Neoplasia (New York, N.Y.). 5: 475-80. PMID 14965440 DOI: 10.1016/S1476-5586(03)80031-3 |
0.381 |
|
| 2003 |
Burgermeister E, Tencer L, Liscovitch M. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. Oncogene. 22: 3888-900. PMID 12813462 DOI: 10.1038/Sj.Onc.1206625 |
0.478 |
|
| 2002 |
Tang X, Waksman M, Ely Y, Liscovitch M. Characterization and regulation of yeast Ca2+-dependent phosphatidylethanolamine-phospholipase D activity. European Journal of Biochemistry / Febs. 269: 3821-30. PMID 12153579 DOI: 10.1046/J.1432-1033.2002.03073.X |
0.363 |
|
| 2002 |
Fiucci G, Ravid D, Reich R, Liscovitch M. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene. 21: 2365-75. PMID 11948420 DOI: 10.1038/Sj.Onc.1205300 |
0.514 |
|
| 2001 |
Lavie Y, Fiucci G, Liscovitch M. Upregulation of caveolin in multidrug resistant cancer cells: functional implications. Advanced Drug Delivery Reviews. 49: 317-23. PMID 11551402 DOI: 10.1016/S0169-409X(01)00144-2 |
0.447 |
|
| 2000 |
Lavie Y, Liscovitch M. Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences. Glycoconjugate Journal. 17: 253-9. PMID 11201798 DOI: 10.1023/A:1026553626537 |
0.449 |
|
| 2000 |
Liscovitch M, Lavie Y. Multidrug resistance: a role for cholesterol efflux pathways? Trends in Biochemical Sciences. 25: 530-4. PMID 11084360 DOI: 10.1016/S0968-0004(00)01668-6 |
0.439 |
|
| 2000 |
Fiucci G, Czarny M, Lavie Y, Zhao D, Berse B, Blusztajn JK, Liscovitch M. Changes in phospholipase D isoform activity and expression in multidrug-resistant human cancer cells. International Journal of Cancer. Journal International Du Cancer. 85: 882-8. PMID 10709112 DOI: 10.1002/(Sici)1097-0215(20000315)85:6<882::Aid-Ijc24>3.0.Co;2-E |
0.486 |
|
| 2000 |
Czarny M, Fiucci G, Lavie Y, Banno Y, Nozawa Y, Liscovitch M. Phospholipase D2: functional interaction with caveolin in low-density membrane microdomains. Febs Letters. 467: 326-32. PMID 10675563 DOI: 10.1016/S0014-5793(00)01174-1 |
0.381 |
|
| 2000 |
Liscovitch M, Czarny M, Fiucci G, Tang X. Phospholipase D: molecular and cell biology of a novel gene family. Biochemical Journal. 345: 401-415. DOI: 10.1042/Bj3450401 |
0.397 |
|
| 1999 |
Liscovitch M, Czarny M, Fiucci G, Lavie Y, Tang X. Localization and possible functions of phospholipase D isozymes. Biochimica Et Biophysica Acta. 1439: 245-63. PMID 10425399 DOI: 10.1016/S1388-1981(99)00098-0 |
0.427 |
|
| 1999 |
Lavie Y, Fiucci G, Czarny M, Liscovitch M. Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells. Lipids. 34: S57-63. PMID 10419089 DOI: 10.1007/Bf02562229 |
0.432 |
|
| 1999 |
Czarny M, Lavie Y, Fiucci G, Liscovitch M. Localization of phospholipase D in detergent-insoluble, caveolin-rich membrane domains. Modulation by caveolin-1 expression and caveolin-182-101. The Journal of Biological Chemistry. 274: 2717-24. PMID 9915802 DOI: 10.1074/Jbc.274.5.2717 |
0.393 |
|
| 1998 |
Lavie Y, Fiucci G, Liscovitch M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. The Journal of Biological Chemistry. 273: 32380-3. PMID 9829965 DOI: 10.1074/Jbc.273.49.32380 |
0.45 |
|
| 1997 |
Williger BT, Liscovitch M. Ras GTPase-activating protein-associated p62 is a major v-Src-SH3-binding protein. Febs Letters. 403: 35-9. PMID 9038356 DOI: 10.1016/S0014-5793(97)00027-6 |
0.342 |
|
| 1997 |
Waksman M, Tang X, Eli Y, Gerst JE, Liscovitch M. Identification of a novel Ca2+-dependent, phosphatidylethanolamine-hydrolyzing phospholipase D in yeast bearing a disruption in PLD1. The Journal of Biological Chemistry. 272: 36-9. PMID 8995222 DOI: 10.1074/Jbc.272.1.36 |
0.353 |
|
| 1996 |
Liscovitch M. Phospholipase D: role in signal transduction and membrane traffic. Journal of Lipid Mediators and Cell Signalling. 14: 215-21. PMID 8906565 DOI: 10.1016/0929-7855(96)00528-7 |
0.406 |
|
| 1996 |
Liscovitch M, Chalifa-Caspi V. Enzymology of mammalian phospholipases D: in vitro studies. Chemistry and Physics of Lipids. 80: 37-44. PMID 8681428 DOI: 10.1016/0009-3084(96)02544-3 |
0.33 |
|
| 1996 |
Waksman M, Eli Y, Liscovitch M, Gerst JE. Identification and characterization of a gene encoding phospholipase D activity in yeast. The Journal of Biological Chemistry. 271: 2361-4. PMID 8576189 DOI: 10.1074/Jbc.271.5.2361 |
0.387 |
|
| 1995 |
Williger BT, Reich R, Neeman M, Bercovici T, Liscovitch M. Release of gelatinase A (matrix metalloproteinase 2) induced by photolysis of caged phosphatidic acid in HT 1080 metastatic fibrosarcoma cells. The Journal of Biological Chemistry. 270: 29656-9. PMID 8530350 DOI: 10.1074/Jbc.270.50.29656 |
0.363 |
|
| 1995 |
Reich R, Blumenthal M, Liscovitch M. Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells. Clinical & Experimental Metastasis. 13: 134-40. PMID 7882615 DOI: 10.1007/Bf00133618 |
0.394 |
|
| 1994 |
Lavie Y, Blusztajn JK, Liscovitch M. Formation of endogenous free sphingoid bases in cells induced by changing medium conditions. Biochimica Et Biophysica Acta. 1220: 323-8. PMID 8305506 DOI: 10.1016/0167-4889(94)90156-2 |
0.359 |
|
| 1993 |
Ben-Av P, Eli Y, Schmidt US, Tobias KE, Liscovitch M. Distinct mechanisms of phospholipase D activation and attenuation utilized by different mitogens in NIH-3T3 fibroblasts. European Journal of Biochemistry / Febs. 215: 455-63. PMID 8344313 DOI: 10.1111/J.1432-1033.1993.Tb18054.X |
0.336 |
|
| 1993 |
Danin M, Chalifa V, Möhn H, Schmidt U, Liscovitch M. [2] – Rat Brain Membrane-Bound Phospholipase D Methods in Neurosciences. 18: 14-24. DOI: 10.1016/B978-0-12-185285-6.50008-7 |
0.313 |
|
| 1992 |
Aridor-Piterman O, Lavie Y, Liscovitch M. Bimodal distribution of phosphatidic acid phosphohydrolase in NG108-15 cells. Modulation by the amphiphilic lipids oleic acid and sphingosine. European Journal of Biochemistry / Febs. 204: 561-8. PMID 1541271 DOI: 10.1111/J.1432-1033.1992.Tb16668.X |
0.338 |
|
| 1992 |
Liscovitch M. Crosstalk among multiple signal-activated phospholipases. Trends in Biochemical Sciences. 17: 393-9. PMID 1455508 DOI: 10.1016/0968-0004(92)90007-V |
0.333 |
|
| 1991 |
Liscovitch M, Chalifa V, Danin M, Eli Y. Inhibition of neural phospholipase D activity by aminoglycoside antibiotics. The Biochemical Journal. 279: 319-21. PMID 1930152 DOI: 10.1042/Bj2790319 |
0.331 |
|
| 1991 |
Liscovitch M. Signal-dependent activation of phosphatidylcholine hydrolysis: role of phospholipase D. Biochemical Society Transactions. 19: 402-7. PMID 1889622 DOI: 10.1042/Bst0190402 |
0.313 |
|
| 1990 |
Lavie Y, Piterman O, Liscovitch M. Inhibition of phosphatidic acid phosphohydrolase activity by sphingosine. Dual action of sphingosine in diacylglycerol signal termination. Febs Letters. 277: 7-10. PMID 2269371 DOI: 10.1016/0014-5793(90)80796-L |
0.373 |
|
| 1989 |
Ben-Av P, Liscovitch M. Phospholipase D activation by the mitogens platelet-derived growth factor and 12-O-tetradecanoylphorbol 13-acetate in NIH-3T3 cells. Febs Letters. 259: 64-6. PMID 2599112 DOI: 10.1016/0014-5793(89)81495-4 |
0.345 |
|
| Show low-probability matches. |